| P50 | author | Qiang Wang | Q96177284 |
| P2093 | author name string | Wangming Zhang | |
| P2860 | cites work | Signaling in dendritic spines and spine microdomains | Q26828892 |
| | The thalamostriatal system in normal and diseased states | Q26996624 |
| | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Q27002626 |
| | Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease | Q29346490 |
| | Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 |
| | RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits | Q30504550 |
| | Concurrent activation of striatal direct and indirect pathways during action initiation. | Q30579307 |
| | Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. | Q30594829 |
| | Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia | Q30650489 |
| | Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia | Q30988635 |
| | Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia | Q33255884 |
| | Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice | Q34490801 |
| | A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression | Q35024117 |
| | Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments | Q35208420 |
| | Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia | Q35574934 |
| | Cerebellar processing of sensory inputs primes motor cortex plasticity | Q36516121 |
| | Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice | Q36599026 |
| | Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 |
| | M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia | Q36892615 |
| | Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses | Q37048087 |
| | Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease | Q37220785 |
| | Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines | Q37479508 |
| | Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. | Q37631957 |
| | Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. | Q37794467 |
| | Current options and future possibilities for the treatment of dyskinesia and motor fluctuations in Parkinson's disease | Q37916641 |
| | New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors | Q37974709 |
| | Electrical compartmentalization in dendritic spines | Q38110905 |
| | Dopaminergic modulation of striatal networks in health and Parkinson's disease | Q38233462 |
| | Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment | Q39398723 |
| | Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. | Q39426286 |
| | Substance P Weights Striatal Dopamine Transmission Differently within the Striosome-Matrix Axis | Q40825163 |
| | Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. | Q41110130 |
| | Selective expression of one Ca(2+)-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions | Q41484982 |
| | Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models | Q41584434 |
| | L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. | Q42440010 |
| | Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia | Q42452008 |
| | Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia. | Q42459246 |
| | Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia | Q42463817 |
| | Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. | Q42477740 |
| | Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. | Q42494976 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients | Q42712278 |
| | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. | Q42852538 |
| | Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. | Q43198758 |
| | Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation. | Q44050773 |
| | Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 |
| | Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias | Q44807332 |
| | Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. | Q45007596 |
| | L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies | Q45228276 |
| | Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. | Q45923687 |
| | Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. | Q45972521 |
| | Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients | Q46218711 |
| | Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. | Q46589894 |
| | ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice | Q46684571 |
| | Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. | Q46859525 |
| | Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 |
| | l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation | Q46904268 |
| | Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia | Q48124096 |
| | Cloning and expression of an adenylyl cyclase localized to the corpus striatum | Q48332642 |
| | RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion | Q48540394 |
| | Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. | Q48545028 |
| | Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease. | Q48579768 |
| | Abnormal bidirectional plasticity-like effects in Parkinson's disease | Q48829642 |
| | L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus | Q48873583 |
| | Parkinson's Disease: A Thalamostriatal Rebalancing Act? | Q48895295 |
| | Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. | Q50545965 |
| | Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias | Q57951136 |
| | The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease | Q60715991 |
| | Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease | Q68502274 |
| | Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors | Q73189222 |
| | Morphologic changes of dendritic spines of striatal neurons in the levodopa-induced dyskinesia model | Q87366704 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | amino acid | Q8066 |
| | nervous system | Q9404 |
| | amine | Q167198 |
| | dopamine | Q170304 |
| | hydrocarbon | Q43648 |
| | phenol | Q407142 |
| | basal ganglia | Q464210 |
| | dyskinesia | Q629444 |
| | neuroplasticity | Q849491 |
| | synaptic plasticity | Q1551556 |
| P304 | page(s) | 105 | |
| P577 | publication date | 2016-12-20 | |
| P1433 | published in | Frontiers in neural circuits | Q27721914 |
| P1476 | title | Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia | |
| P478 | volume | 10 | |